Clinical Trials Browser

INDUSTRY × Advanced Malignancies × spartalizumab × Clear all

NCT02678260 2018-06-08

Phase I Study of PDR001 in Patients With Advanced Malignancies.

Phase 1 Completed

Advanced Malignancies